Intravitreal low molecular weight heparin and 5‐Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravitreal Low Molecular Weight Heparin and 5‐Fluorouracil for the Prevention of Proliferative Vitreoretinopathy Following Retinal Reattachment Surgery." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438361/all/Intravitreal_low_molecular_weight_heparin_and_5‐Fluorouracil_for_the_prevention_of_proliferative_vitreoretinopathy_following_retinal_reattachment_surgery.
Intravitreal low molecular weight heparin and 5‐Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438361/all/Intravitreal_low_molecular_weight_heparin_and_5‐Fluorouracil_for_the_prevention_of_proliferative_vitreoretinopathy_following_retinal_reattachment_surgery. Accessed March 15, 2025.
Intravitreal low molecular weight heparin and 5‐Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438361/all/Intravitreal_low_molecular_weight_heparin_and_5‐Fluorouracil_for_the_prevention_of_proliferative_vitreoretinopathy_following_retinal_reattachment_surgery
Intravitreal Low Molecular Weight Heparin and 5‐Fluorouracil for the Prevention of Proliferative Vitreoretinopathy Following Retinal Reattachment Surgery [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438361/all/Intravitreal_low_molecular_weight_heparin_and_5‐Fluorouracil_for_the_prevention_of_proliferative_vitreoretinopathy_following_retinal_reattachment_surgery.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravitreal low molecular weight heparin and 5‐Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery
ID - 438361
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438361/all/Intravitreal_low_molecular_weight_heparin_and_5‐Fluorouracil_for_the_prevention_of_proliferative_vitreoretinopathy_following_retinal_reattachment_surgery
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -